MYH3 Gene Arthrogryposis Distal Type 2A NGS Genetic DNA Test
Comprehensive Genetic Analysis for Joint Contracture Disorders
The MYH3 Gene Arthrogryposis Distal Type 2A NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with distal arthrogryposis type 2A. This specialized test utilizes Next-Generation Sequencing (NGS) technology to provide comprehensive analysis of the MYH3 gene, which plays a crucial role in skeletal muscle development and function.
What Does This Test Measure?
This advanced genetic test specifically targets the MYH3 gene, which encodes the embryonic myosin heavy chain protein. The test detects:
- Pathogenic variants and mutations in the MYH3 gene
- Single nucleotide polymorphisms (SNPs) associated with distal arthrogryposis
- Copy number variations affecting gene function
- Novel genetic variants that may contribute to disease manifestation
Who Should Consider This Test?
This genetic test is recommended for individuals presenting with:
- Congenital joint contractures affecting hands and feet
- Family history of distal arthrogryposis type 2A
- Unexplained skeletal abnormalities at birth
- Facial features including micrognathia, down-slanting palpebral fissures, or cleft palate
- Planned pregnancy with known family history of MYH3 mutations
- Unexplained developmental delays with skeletal involvement
Clinical Benefits of Genetic Testing
Undergoing the MYH3 gene test provides numerous clinical advantages:
- Accurate Diagnosis: Confirms or rules out distal arthrogryposis type 2A
- Family Planning: Enables informed reproductive decisions
- Treatment Guidance: Helps develop targeted management strategies
- Prognostic Information: Provides insight into disease progression
- Genetic Counseling: Supports comprehensive family genetic assessment
Understanding Your Test Results
Your genetic test results will be carefully interpreted by our expert geneticists:
- Positive Result: Indicates the presence of pathogenic MYH3 gene mutations associated with distal arthrogryposis type 2A
- Negative Result: Suggests no detectable mutations in the MYH3 gene, though clinical correlation is essential
- Variant of Uncertain Significance: Identifies genetic changes with unknown clinical impact requiring further evaluation
- Carrier Status: Determines if you carry one copy of a mutated gene
Test Details and Pricing
| Test Component | Details |
|---|---|
| Test Name | MYH3 Gene Arthrogryposis Distal Type 2A NGS Genetic DNA Test |
| Discount Price | $500 USD |
| Regular Price | $700 USD |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type | Blood, Extracted DNA, or One Drop Blood on FTA Card |
| Testing Method | Next-Generation Sequencing (NGS) |
Pre-Test Requirements
Before scheduling your test, please ensure:
- Complete clinical history documentation
- Genetic counseling session scheduled
- Family pedigree chart prepared
- Informed consent obtained
Nationwide Testing Availability
We proudly serve patients across the United States with convenient testing locations in all major cities including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our state-of-the-art laboratories ensure consistent, reliable results nationwide.
Take the Next Step Toward Genetic Clarity
Don’t let uncertainty about genetic conditions affect your health decisions. Our comprehensive MYH3 gene testing provides the answers you need for informed medical care and family planning. With our discounted price of $500 USD, advanced genetic testing is more accessible than ever.
Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic test consultation and take control of your genetic health journey.
